Chitosan oligosaccharide promotes osteoclast formation by stimulating the activation of MAPK and AKT signaling pathways
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chitosan oligosaccharide promotes osteoclast formation by stimulating the activation of MAPK and AKT signaling pathways
Authors
Keywords
-
Journal
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
Volume 29, Issue 10, Pages 1207-1218
Publisher
Informa UK Limited
Online
2018-03-03
DOI
10.1080/09205063.2018.1448336
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chitosan as biomaterial in drug delivery and tissue engineering
- (2018) Saad M. Ahsan et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Macrolactin F inhibits RANKL-mediated osteoclastogenesis by suppressing Akt, MAPK and NFATc1 pathways and promotes osteoblastogenesis through a BMP-2/smad/Akt/Runx2 signaling pathway
- (2017) Liang Li et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Chitosan as a bioactive polymer: Processing, properties and applications
- (2017) A. Muxika et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Hemostatic gauze based on chitosan and hydroquinone: preparation, characterization and blood coagulation evaluation
- (2017) Roberta Cassano et al. JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
- Chitosan oligosaccharide: Biological activities and potential therapeutic applications
- (2017) Chatchai Muanprasat et al. PHARMACOLOGY & THERAPEUTICS
- Selective Modification of Chitin and Chitosan: En Route to Tailored Oligosaccharides
- (2016) Luísa C. R. Carvalho et al. Chemistry-An Asian Journal
- Advances in characterisation and biological activities of chitosan and chitosan oligosaccharides
- (2016) Pan Zou et al. FOOD CHEMISTRY
- Lycorine suppresses RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced osteoporosis and titanium particle-induced osteolysis in vivo
- (2015) Shuai Chen et al. Scientific Reports
- Hypericin suppresses osteoclast formation and wear particle-induced osteolysis via modulating ERK signalling pathway
- (2014) Zhengxiao Ouyang et al. BIOCHEMICAL PHARMACOLOGY
- The prevention of titanium-particle-induced osteolysis by OA-14 through the suppression of the p38 signaling pathway and inhibition of osteoclastogenesis
- (2014) Bo Tian et al. BIOMATERIALS
- The potential role of free chitosan in bone trauma and bone cancer management
- (2014) Mei L. Tan et al. BIOMATERIALS
- The effect of enoxacin on osteoclastogenesis and reduction of titanium particle-induced osteolysis via suppression of JNK signaling pathway
- (2014) Xuqiang Liu et al. BIOMATERIALS
- Effects of Eleutheroside B and Eleutheroside E on activity of cytochrome P450 in rat liver microsomes
- (2014) Sixun Guo et al. BMC Complementary and Alternative Medicine
- Chitosan coating to enhance the therapeutic efficacy of calcium sulfate-based antibiotic therapy in the treatment of chronic osteomyelitis
- (2014) Karen E Beenken et al. JOURNAL OF BIOMATERIALS APPLICATIONS
- Fibrinogen promotes resorption of chitosan by human osteoclasts
- (2013) A.L. Torres et al. Acta Biomaterialia
- Marine Compounds with Therapeutic Potential in Gram-Negative Sepsis
- (2013) Tamara Solov'eva et al. Marine Drugs
- New insights into osteoclastogenic signaling mechanisms
- (2012) Tomoki Nakashima et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Chitosan Modification and Pharmaceutical/Biomedical Applications
- (2010) Jiali Zhang et al. Marine Drugs
- Differentiation and activity of human preosteoclasts on chitosan enriched calcium phosphate cement
- (2009) Nathalie Rochet et al. BIOMATERIALS
- Osteoblast: Osteoclast co-cultures on silk fibroin, chitosan and PLLA films
- (2009) Gemma L. Jones et al. BIOMATERIALS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started